Advertisement
Screener

WAVE LIFE SCIENCES LTD. (WVE) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

WAVE LIFE SCIENCES LTD. Earnings Per Share, Basic and Diluted

WAVE LIFE SCIENCES LTD. (WVE) reported Earnings Per Share, Basic and Diluted of -$0.62 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12

  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.62.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.12.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.78.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.86.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for fiscal 2021 was -$2.36.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for fiscal 2020 was -$3.82.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for fiscal 2019 was -$5.72.
  • WAVE LIFE SCIENCES LTD. earnings per share, basic and diluted for fiscal 2018 was -$5.06.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2022-03-31-$0.62
10-Q · filed 2022-05-12
2021-12-31-$2.36
10-K · filed 2022-03-03
2021-09-30-$0.12
10-Q · filed 2021-11-10
-$1.75
10-Q · filed 2021-11-10
2021-06-30-$0.78
10-Q · filed 2021-08-05
-$1.65
10-Q · filed 2021-08-05
2021-03-31-$0.86
10-Q · filed 2022-05-12
2020-12-31-$3.82
10-K · filed 2022-03-03
2020-09-30-$0.86
10-Q · filed 2021-11-10
-$3.36
10-Q · filed 2021-11-10
2020-06-30-$1.15
10-Q · filed 2021-08-05
-$2.53
10-Q · filed 2021-08-05
2020-03-31-$1.38
10-Q · filed 2021-05-13
2019-12-31-$1.65
10-K · filed 2020-03-02
-$5.72
10-K · filed 2021-03-04
2019-09-30-$1.48
10-Q · filed 2020-11-09
-$4.06
10-Q · filed 2020-11-09
2019-06-30-$1.22
10-Q · filed 2020-08-10
-$2.58
10-Q · filed 2020-08-10
2019-03-31-$1.36
10-Q · filed 2020-05-11
2018-12-31-$1.29
10-K · filed 2020-03-02
-$5.06
10-K · filed 2020-03-02
2018-09-30-$1.28
10-K · filed 2020-03-02
-$3.78
10-Q · filed 2019-11-05
2018-06-30-$1.23
10-K · filed 2020-03-02
-$2.49
10-Q · filed 2019-08-06
2018-03-31-$1.26
10-K · filed 2020-03-02
2017-12-31-$1.11
10-K · filed 2019-03-01
-$1.09
10-K · filed 2018-03-12
-$3.85
10-K · filed 2020-03-02
2017-09-30-$0.92
10-K · filed 2019-03-01
-$0.94
10-Q · filed 2017-11-09
-$2.73
10-Q · filed 2018-11-09
-$2.75
10-Q · filed 2017-11-09
2017-06-30-$0.91
10-K · filed 2019-03-01
-$0.92
10-Q · filed 2017-08-09
-$1.81
10-Q · filed 2018-08-09
2017-03-31-$0.90
10-K · filed 2019-03-01
-$0.89
10-Q · filed 2017-05-10
2016-12-31-$0.79
10-K · filed 2018-03-12
-$2.44
10-K · filed 2019-03-01
-$2.43
10-K · filed 2017-03-16
2016-09-30-$0.75
10-K · filed 2018-03-12
-$1.64
10-Q · filed 2017-11-09
2016-06-30-$0.51
10-K · filed 2018-03-12
-$0.88
10-Q · filed 2017-08-09
2016-03-31-$0.36
10-K · filed 2018-03-12
2015-12-31-$0.46
10-K · filed 2017-03-16
-$1.83
10-K · filed 2018-03-12
2015-09-30-$0.54
10-K · filed 2017-03-16
-$1.36
10-Q · filed 2016-11-09
2015-06-30-$0.40
10-K · filed 2017-03-16
-$0.82
10-Q · filed 2016-08-15
2015-03-31-$0.42
10-K · filed 2017-03-16
2014-12-31-$0.41
10-K · filed 2016-03-30
-$1.34
10-K · filed 2017-03-16
2014-09-30-$0.32
10-K · filed 2016-03-30
-$0.92
10-Q · filed 2015-12-17
2014-06-30-$0.40
10-K · filed 2016-03-30
2014-03-31-$0.14
10-K · filed 2016-03-30
2013-12-31-$1.90
10-K · filed 2016-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
GERON CORP (GERN)United States$0.803B-12.14
Faeth Therapeutics, Inc. (FTH)United States$0.750B
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44